Traws Pharma, Inc.
For the period ended Jun 30, 2026. Filed Aug 14, 2026.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Jun 30, 2026 · Filed Aug 14, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Item 6. Exhibits
EXHIBIT INDEX
| ExhibitNumber | | Description |
| 4.1 | | Form of Pre-Funded Warrant issued to the selling stockholders (incorporated herein by reference to Exhibit 4.1 to the Company’s Current Report on Form 8-K filed with the SEC on April 15, 2026). |
| 4.2 | | Form of Series A Warrant issued to the selling stockholders (incorporated herein by reference to Exhibit 4.2 to the Company’s Current Report on Form 8-K filed with the SEC on April 15, 2026). |
| 4.3 | | Form of Series B Warrant issued to the selling stockholders (incorporated herein by reference to Exhibit 4.3 to the Company’s Current Report on Form 8-K filed with the SEC on April 15, 2026). |
| 4.4 | | Form of Series C Warrant issued to the selling stockholders (incorporated herein by reference to Exhibit 4.4 to the Company’s Current Report on Form 8-K filed with the SEC on April 15, 2026). |
| 10.1 | | Form of Securities Purchase Agreement entered into by and between the Company and the selling stockholders, dated April 15, 2026 (incorporated herein by reference to Exhibit 10.1 to the Company’s Current Report on Form 8-K filed with the SEC on April 15, 2026). |
| 10.2 | | Form of Registration Rights Agreement entered into by and between the Company and certain of the selling stockholders, dated April 15, 2026 (incorporated herein by reference to Exhibit 10.2 to the Company’s Current Report on Form 8-K filed with the SEC on April 15, 2026). |
| 10.3+ | | First Amendment to the Traws Pharma, Inc. 2021 Incentive Compensation Plan (incorporated herein by reference to Exhibit 10.1 to the Company's Current Report on Form 8-K filed with the SEC on July 9, 2026). |
| 31.1 | * | Rule 13a-14(a)/15d-14(a) Certifications of Principal Executive Officer |
| 31.2 | * | Rule 13a-14(a)/15d-14(a) Certifications of Principal Financial Officer |
| 32.1 | ** | Section 1350 Certifications of Principal Executive Officer |
| 32.2 | ** | Section 1350 Certifications of Principal Financial Officer |
| 101.INS | † | Inline XBRL Instance Document – The instance document does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document |
| 101.SCH | † | Inline XBRL Taxonomy Extension Schema With Embedded Linkbase Documents |
| 104 | † | Cover Page Interactive Data File -The cover page interactive data file does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document |
- Filed herewith
** Furnished herewith
- Indicates management contract or compensatory plan.
† The XBRL related information in Exhibit 101 shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, or otherwise subject to liability of that section and shall not be incorporated by reference into any filing or other document pursuant to the Securities Act of 1933, as amended, except as shall be expressly set forth by specific reference in such filing or document.
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.